Actively Recruiting
Steps Against the Burden of Parkinson's Disease
Led by The University of New South Wales · Updated on 2025-07-17
42
Participants Needed
1
Research Sites
72 weeks
Total Duration
On this page
Sponsors
T
The University of New South Wales
Lead Sponsor
N
Neuroscience Research Australia
Collaborating Sponsor
AI-Summary
What this Trial Is About
Parkinson's Disease Treadmill Training RCT Summary Parkinson's disease (PD) affects over 10 million people globally. Despite optimal pharmacological treatment, approximately 70% of individuals experience unstable gait and falls, leading to loss of confidence, social isolation, fractures, and frequent hospitalisations. Treadmill training-especially when augmented by mechanical or virtual-reality perturbations-has shown promise in improving gait and reducing fall risk. However, the mechanisms underlying these benefits remain poorly understood, limiting the ability to personalise interventions effectively. This randomised controlled trial (RCT) forms part of the broader Steps Against the Burden of Parkinson's Disease project (CT-IDs: 6ef2e427b002, 6ef2e427b003, 6ef2e427b004), comprising three harmonised but independently conducted RCTs. All sites follow a shared core protocol, allowing for pooled data analysis while preserving site-specific perturbation adaptations. Findings from this trial will be reported both independently and as part of the combined dataset. In this trial, participants with PD will undergo 12 sessions of treadmill training, with or without virtual reality and perturbation-based adaptations. Assessments will be conducted at baseline, post-training, and follow-up. The intervention aims to enhance gait through improved sensorimotor integration and balance control. During the follow-up period, a smartphoneapp "Walking Tall" will be used to encourage continued exercises and long-term retention of training effects. Biomechanical analyses will focus on changes in foot placement control. Neurophysiological outcomes will be examined using EEG and EMG, targeting reductions in beta-band EEG power and enhanced EEG-EMG coherence as markers of improved gait stability. Recognising that laboratory-based improvements may not always translate to daily life, this study will also investigate gait self-efficacy as a potential moderator of transfer. Remote monitoring tools will capture real-world mobility outcomes over a week. Machine learning techniques will be employed to identify factors differentiating those who improve in both settings from those who do not. These insights will inform the development of personalised interventions capable of translating training effects into meaningful real-life outcomes.
CONDITIONS
Official Title
Steps Against the Burden of Parkinson's Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Parkinson's disease according to the MDS Criteria
- Hoehn and Yahr stages I to III
- Movement Disorder Society-sponsored version of the Unified Parkinson Disease Rating Scale (MDS-UPDRS) gait sub-score of 1 or more
- Signed informed consent to participation
You will not qualify if you...
- Any known general health condition likely to interfere with or to pose a contraindication to non-medically supervised physical exercise
- Moderate or severe depression (BDI-II 6518)
- Cognitive impairment preventing fully informed consent
- Linguistic comprehension less than 75% in ordinary conversation
- Severe psychiatric comorbidity that may affect study compliance
- History of or current substance dependency
- Unable to walk less than 1 floor
- Thoracic pain in the last 4 weeks
- Currently enrolled in other interventional studies
- Implanted Deep Brain Stimulation device
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Neuroscience Research Australia
Randwick, New South Wales, Australia, 2031
Actively Recruiting
Research Team
M
Matthew A Brodie, PhD
CONTACT
Y
Yoshiro Okubo, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here